Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-04

FDA Approved: PRASUGREL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application from Aurobindo Pharma Limited for prasugrel, providing a generic version of the antiplatelet drug used to reduce cardiov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)